DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 892 filers reported holding DANAHER CORPORATION in Q1 2014. The put-call ratio across all filers is 0.37 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $4,731 | +26.0% | 19,068 | +21.9% | 0.03% | +26.1% |
| Q2 2023 | $3,754 | -13.6% | 15,642 | -9.3% | 0.02% | -20.7% |
| Q1 2023 | $4,345 | -9.5% | 17,238 | -4.7% | 0.03% | -17.1% |
| Q4 2022 | $4,799 | -99.9% | 18,082 | +1.7% | 0.04% | -2.8% |
| Q3 2022 | $4,593,000 | +25.5% | 17,782 | +23.1% | 0.04% | +28.6% |
| Q2 2022 | $3,661,000 | -4.7% | 14,440 | +10.2% | 0.03% | +3.7% |
| Q1 2022 | $3,843,000 | -5.8% | 13,102 | +5.7% | 0.03% | -6.9% |
| Q4 2021 | $4,080,000 | +40.7% | 12,400 | +14.8% | 0.03% | +26.1% |
| Q2 2021 | $2,900,000 | 0.0% | 10,806 | 0.0% | 0.02% | 0.0% |
| Q1 2021 | $2,900,000 | 0.0% | 10,806 | 0.0% | 0.02% | 0.0% |
| Q4 2020 | $2,900,000 | 0.0% | 10,806 | 0.0% | 0.02% | 0.0% |
| Q3 2020 | $2,900,000 | 0.0% | 10,806 | 0.0% | 0.02% | 0.0% |
| Q2 2020 | $2,900,000 | 0.0% | 10,806 | 0.0% | 0.02% | 0.0% |
| Q1 2020 | $2,900,000 | 0.0% | 10,806 | 0.0% | 0.02% | 0.0% |
| Q4 2019 | $2,900,000 | 0.0% | 10,806 | 0.0% | 0.02% | 0.0% |
| Q3 2019 | $2,900,000 | 0.0% | 10,806 | 0.0% | 0.02% | 0.0% |
| Q2 2019 | $2,900,000 | 0.0% | 10,806 | 0.0% | 0.02% | 0.0% |
| Q1 2019 | $2,900,000 | +451.3% | 10,806 | +111.9% | 0.02% | +76.9% |
| Q4 2018 | $526,000 | +0.2% | 5,100 | +5.6% | 0.01% | 0.0% |
| Q3 2018 | $525,000 | +21.0% | 4,831 | +9.8% | 0.01% | -7.1% |
| Q2 2018 | $434,000 | +5.3% | 4,398 | +4.4% | 0.01% | -12.5% |
| Q1 2018 | $412,000 | +5.1% | 4,212 | -0.4% | 0.02% | -5.9% |
| Q4 2017 | $392,000 | +7.1% | 4,227 | -0.9% | 0.02% | 0.0% |
| Q3 2017 | $366,000 | +24.9% | 4,267 | +23.1% | 0.02% | +13.3% |
| Q2 2017 | $293,000 | +0.7% | 3,467 | +1.8% | 0.02% | -6.2% |
| Q1 2017 | $291,000 | +6.2% | 3,406 | -3.2% | 0.02% | -5.9% |
| Q4 2016 | $274,000 | +85.1% | 3,519 | +87.0% | 0.02% | +70.0% |
| Q3 2016 | $148,000 | -22.1% | 1,882 | 0.0% | 0.01% | -28.6% |
| Q2 2016 | $190,000 | -2.6% | 1,882 | -8.3% | 0.01% | -17.6% |
| Q1 2016 | $195,000 | +182.6% | 2,053 | +175.6% | 0.02% | +142.9% |
| Q4 2015 | $69,000 | +64.3% | 745 | +36.9% | 0.01% | 0.0% |
| Q4 2013 | $42,000 | +16.7% | 544 | +5.6% | 0.01% | -22.2% |
| Q3 2013 | $36,000 | – | 515 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CROSBY Co OF NEW HAMPSHIRE LLC | 224,667 | $17,688,000 | 10.64% |
| RobecoSam USA, Inc. | 102,422 | $8,063,000 | 8.78% |
| CORTLAND ASSOCIATES INC/MO | 466,424 | $36,722,000 | 7.33% |
| Red Rocks Capital LLC | 324,527 | $25,550,000 | 7.05% |
| Five Oceans Asset Management LTD | 327,112 | $25,754,000 | 5.88% |
| Robeco Schweiz AG | 739,101 | $58,529,000 | 4.77% |
| TRAN CAPITAL MANAGEMENT, L.P. | 3,428,966 | $269,962,000 | 4.72% |
| ASHMORE WEALTH MANAGEMENT LLC | 3,000,000 | $236,192,000 | 4.56% |
| CADINHA & CO LLC | 324,429 | $25,542,000 | 4.31% |
| BI Asset Management Fondsmaeglerselskab A/S | 503,250 | $39,621,000 | 4.31% |